Crescent forms PD-1xVEGF, ADC pact with Kelun, raises $185M
Crescent组建PD-1xVEGF、抗体药物偶联物合作，与科伦达成协议，并融资1.85亿美元

Crescent Biopharma made a set of sweeping moves Thursday morning, notably with its strategy of bringing its PD-1xVEGF to China.
Crescent Biopharma于周四早间采取了一系列大动作，尤以其将PD-1xVEGF引入manbetx3.0 的战略最为引人注目。